Image
Page header image.
Image
Page header image.

Author: University of Edinburgh

Source: Medical Xpress

Publish date: October 23, 2024

AI tool predicts risk of emergency hospital visits

Experts have harnessed the power of artificial intelligence (AI) to more accurately anticipate which patients will require emergency hospital admissions across Scotland.

Researchers employed machine learning to develop an update for the first time in 12 years for a tool used by health care providers to highlight individuals at high risk of urgent hospital care within the next year.

In tests they found that SPARRAv4—Scottish Patients At Risk of Readmission and Admission version 4—is better able to identify emergency admissions than the previous version.

Researchers say the AI-powered update can help health care providers in Scotland anticipate and plan more effectively for emergency cases and manage health care resources more efficiently. The research is published in the journal npj Digital Medicine.

Reducing strain

Emergency hospital admissions routinely account for around half of all hospital stays in Scotland, placing tremendous strain on the health care system.

Researchers from the Universities of Edinburgh and Durham worked with Public Health Scotland to develop an improved tool to help manage this growing issue.

The team used health records from 4.8 million people living in Scotland, gathered between 2013 and 2018, and held by Public Health Scotland. The records included information that is routinely collected by health care providers, such as patient history, prescription details and previous hospital admissions.“

In an era when health care systems are under high stress, we hope that the availability of robust and reproducible risk prediction scores such as SPARRAv4 will contribute to the design of proactive interventions that reduce pressures on health care systems and improve healthy life expectancy,” says Dr. Catalina Vallejos, reader at the University of Edinburgh’s MRC Human Genetics Unit.

Improved accuracy

Experts used machine learning techniques to analyse the dataset and developed SPARRAv4 to predict which patients might require emergency hospital care within a 12-month period.

As well as correctly identifying more emergency admissions, SPARRAv4 was also found to be better at gauging individual patients’ level of risk of needing urgent hospital care.

Researchers highlight that while the tool will serve as a critical aid, it will not replace the essential clinical judgment of medical professionals.

Public Health Scotland will start promoting the updated model and engaging with health care professionals to encourage its widespread adoption in Scotland.

“AI and machine learning depend on large amounts of high-quality data and secure platforms. Thanks to Public Health Scotland’s exceptional data curation, this research collaboration has developed a model that could greatly benefit the public.

“This demonstrates how big data can create tools to support medical professionals when identifying patients who might benefit from early intervention,” says Dr. Louis Aslett, associate professor of statistics at Durham University

“The SPARRA model was developed to respond to a growing recognition of the need to shift from reactive health care to a more preventative and anticipatory approach.

“This has been a fruitful research collaboration between Public Health Scotland and colleagues from the Alan Turing Institute, to harness the power of Scotland’s data, through the use of innovative statistical and AI techniques to update our SPARRA model,” says Dr. Jill Ireland, principal analyst at Public Health Scotland.

More information

This article was from Medical Xpress and was licensed to Novartis for Novartis’ use by the Industry Dive Content Marketplace. Please direct all licensing questions to [email protected].

Image
Medical Xpress logo

Related content

UK | January 2026 | FA-11573350

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.